Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections
Clinical trial NCT05060419 · UNKNOWN
Trial details
- NCT number
- NCT05060419
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-08
- Primary completion
- 2022-04-29
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.